Biology of Osteosarcoma (BOOST) Registry and Biobank
| Status: | Recruiting |
|---|---|
| Conditions: | Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 3/23/2019 |
| Start Date: | January 3, 2017 |
| End Date: | December 2050 |
| Contact: | Michelle A Roesler, BS |
| Email: | roesl003@umn.edu |
| Phone: | 1-866-434-9879 |
Osteosarcoma is very rare cancer of the bone. The investigator started the BOOST registry and
biobank to make sure every patient has the opportunity to participate in research.
biobank to make sure every patient has the opportunity to participate in research.
Summary to include:
1. Samples of saliva, blood and/or other stored material such as slides or leftover
diagnostic material. If available the investigator may ask you for deciduous (baby)
teeth.
2. Questionnaire information, including health history, growth and development, physical
activity and family medical history information.
3. If you have been diagnosed with a osteosarcoma or another condition the investigator is
interested inthe investigator will ask you release medical record information relating
to diagnosis and treatment of osteosarcoma, other cancers, blood disorders, and similar
conditions. If this step applies to you then you will be asked to sign a separate form.
4. You may be asked to contact your biological parents and full biological siblings to ask
them about participating in the study.
5. If you agree you may be contacted in the future. You will be able to decline any future
information or studies at any point.
1. Samples of saliva, blood and/or other stored material such as slides or leftover
diagnostic material. If available the investigator may ask you for deciduous (baby)
teeth.
2. Questionnaire information, including health history, growth and development, physical
activity and family medical history information.
3. If you have been diagnosed with a osteosarcoma or another condition the investigator is
interested inthe investigator will ask you release medical record information relating
to diagnosis and treatment of osteosarcoma, other cancers, blood disorders, and similar
conditions. If this step applies to you then you will be asked to sign a separate form.
4. You may be asked to contact your biological parents and full biological siblings to ask
them about participating in the study.
5. If you agree you may be contacted in the future. You will be able to decline any future
information or studies at any point.
Inclusion Criteria:
- Proband Inclusion criteria: A diagnosis or suspected diagnosis of osteosarcoma (ICCC
9180-9200)
Family member inclusion criteria: Biological parents and full biological siblings of a case
diagnosed with osteosarcoma (ICCC 9180-9200)
Exclusion Criteria:
- Does not understand English.
We found this trial at
1
site
Minneapolis, Minnesota 55455
Principal Investigator: Logan G Spector, PhD
Phone: 612-624-8933
Click here to add this to my saved trials
